Pancreatic Surgery Practice Questions

Q: What is the gold standard investigation for chronic pancreatitis?

ERCP. **Explanation:** **Correct Answer: B. ERCP** ERCP (Endoscopic Retrograde Cholangiopancreatography) is traditionally considered the **gold standard** for diagnosing chronic pancreatitis because it provides high-resolution visualization of the ductal anatomy. It can detect early changes such as ductal dilation, stenosis, and "chain of lakes" appearance (alternating stenosis and dilation) that other modalities might miss. According to the **Cambridge Classification**, ERCP is the most sensitive test for assessing the severity of ductal changes. **Why other options are incorrect:** * **A. MRI/MRCP:** While MRCP is the non-invasive investigation of choice and is increasingly replacing ERCP in clinical practice due to the lack of radiation and procedural risks (like pancreatitis), it is not yet the academic "gold standard" for ductal morphology. * **C. Pancreatic Function Tests:** Tests like the Secretin-Cholecystokinin test are the most sensitive for detecting **early exocrine insufficiency**, but they are cumbersome, invasive, and do not provide anatomical detail. * **D. Faecal Fat Estimation:** This is used to diagnose steatorrhea (malabsorption). It only becomes positive when >90% of the pancreatic exocrine function is lost, making it a late-stage marker rather than a diagnostic gold standard. **High-Yield Clinical Pearls for NEET-PG:** * **Most sensitive imaging:** Endoscopic Ultrasound (EUS) is now considered the most sensitive for early parenchymal changes. * **Investigation of choice (Initial):** CECT (shows "Chain of Lakes" and calcifications). * **Most specific finding:** Pancreatic calcifications on X-ray or CT. * **Triad of Chronic Pancreatitis:** Steatorrhea, Diabetes Mellitus, and Pancreatic Calcifications.

Q: All are true about Zollinger-Ellison syndrome except?

Decreased basal acid output (BAO)/maximal acid output (MAO). **Explanation:** Zollinger-Ellison Syndrome (ZES) is caused by a gastrin-secreting neuroendocrine tumor (gastrinoma), typically located in the "Gastrinoma Triangle." The hallmark of ZES is **hypergastrinemia**, which leads to massive hypertrophy of gastric parietal cells and excessive acid secretion. **Why Option C is the correct answer (False statement):** In ZES, there is a massive increase in **Basal Acid Output (BAO)**, often >15 mEq/hr. Because the parietal cells are already being maximally stimulated by endogenous gastrin, the **BAO/MAO ratio** is typically **increased** (usually >0.6). A decreased ratio would imply low acid production, which is the opposite of ZES pathophysiology. **Analysis of Incorrect Options (True statements):** * **Option A:** Recurrent or refractory peptic ulcers, especially in atypical locations (e.g., distal duodenum or jejunum) or despite adequate acid-reducing surgery/PPI therapy, are classic indicators of ZES. * **Option B:** Hypergastrinemia is the biochemical hallmark. While levels can fluctuate, a fasting serum gastrin >1000 pg/mL is virtually diagnostic. * **Option D:** Diarrhea occurs in ~50% of patients due to the high volume of acid inactivating pancreatic enzymes (steatorrhea) and direct mucosal injury to the small intestine. **High-Yield Clinical Pearls for NEET-PG:** * **Gastrinoma Triangle (Passaro’s):** Junction of cystic/common bile duct, junction of 2nd/3rd parts of duodenum, and neck/body of pancreas. * **MEN-1 Association:** 25% of ZES cases are associated with Multiple Endocrine Neoplasia Type 1 (3Ps: Parathyroid, Pancreas, Pituitary). * **Best Initial Test:** Fasting Serum Gastrin. * **Most Sensitive Provocative Test:** Secretin Stimulation Test (ZES patients show a paradoxical *increase* in gastrin). * **Localization:** Somatostatin Receptor Scintigraphy (Octreoscan) is the gold standard for imaging.

Q: All of the following can be used to predict severe acute pancreatitis except?

C-reactive protein <100. ### Explanation The severity of acute pancreatitis is defined by the presence of organ failure and local or systemic complications. To predict which patients will develop severe disease, clinicians use various scoring systems and biochemical markers. **Why Option D is the Correct Answer:** C-reactive protein (CRP) is an excellent prognostic marker, but its **threshold for predicting severe acute pancreatitis is >150 mg/L** (measured 48 hours after symptom onset). A CRP level **<100 mg/L** actually suggests a milder course and has a high negative predictive value for severity. Therefore, it cannot be used to predict "severe" pancreatitis. **Analysis of Incorrect Options:** * **A. Glasgow (Imrie) Score ≥ 3:** This is a validated multi-parameter scoring system specifically for pancreatitis. A score of 3 or more within the first 48 hours indicates severe pancreatitis. * **B. APACHE II Score ≥ 8:** This is a general physiological scoring system used in ICUs. An APACHE II score of 8 or more at any point (admission or during the first 48 hours) is a gold standard for predicting severe disease and increased mortality. * **C. CT Severity Index (CTSI) ≥ 6:** Also known as the Balthazar score, it combines CT findings of inflammation and the degree of pancreatic necrosis. A score of 6 or higher correlates strongly with increased morbidity and mortality. **Clinical Pearls for NEET-PG:** * **Ranson’s Criteria:** Still frequently tested; remember that the parameters change between Admission and 48 hours (mnemonic: **GAW LAW** for Glucose, Age, WBC, LDH, AST, Fluid sequestration). * **BISAP Score:** A simple bedside tool (BUN, Impaired mental status, SIRS, Age >60, Pleural effusion). A score ≥3 predicts increased mortality. * **Most common cause of death:** In the first week, it is **SIRS/Organ failure**; after the second week, it is **Sepsis/Infected necrosis**.

Q: Which of the following is NOT an operation for chronic pancreatitis?

None of the above. ### Explanation The correct answer is **None of the above** because all three listed options (Beger’s, Puestow’s/LPJ, and Frey’s) are established surgical interventions for managing chronic pancreatitis. Surgery in chronic pancreatitis is primarily indicated for intractable pain, ductal obstruction, or inflammatory masses in the head of the pancreas. **Analysis of Options:** * **Longitudinal Pancreaticojejunostomy (LPJ/Puestow Procedure):** This is a **drainage procedure**. It is indicated when the main pancreatic duct is dilated (typically >6 mm). The duct is opened longitudinally and anastomosed to a loop of the jejunum. * **Beger’s Procedure (Duodenum-preserving Pancreatic Head Resection - DPPHR):** This is a **resection procedure**. It involves resecting the inflammatory mass in the head of the pancreas while preserving the duodenum and the common bile duct. * **Frey’s Procedure:** This is a **hybrid procedure** (Resection + Drainage). It involves local resection of the pancreatic head (coring out) combined with a longitudinal pancreaticojejunostomy. It is currently the preferred surgery for many surgeons as it addresses both the head mass and ductal hypertension. **High-Yield Clinical Pearls for NEET-PG:** * **Indication for Surgery:** Intractable pain is the most common indication. * **Whipple’s Procedure:** While used for chronic pancreatitis with suspected malignancy, it is generally avoided for benign disease due to higher morbidity compared to DPPHR. * **Chain of Lakes Appearance:** Refers to the alternating segments of dilatation and stenosis in the pancreatic duct seen on ERCP/MRCP in chronic pancreatitis. * **Partington-Rochelle Procedure:** A modification of the Puestow procedure where the tail of the pancreas is not resected.

Q: A 60-year-old woman with a history of chronic pancreatitis presents with worsening epigastric pain radiating to the back, accompanied by nausea and vomiting. She has experienced a 10 kg weight loss over the past 4 months. There is no evidence of jaundice, and liver function tests and serum amylase/lipase levels are within normal limits. A CT scan of the abdomen reveals significant findings. What is the most appropriate next step in managing this patient?

Palliative chemotherapy and best supportive care. ***Palliative chemotherapy and best supportive care*** - Given the significant **weight loss (10 kg)** and **chronic pancreatitis** history with **CT findings** suggesting **unresectable pancreatic malignancy** with likely **vascular encasement** or **metastases**. - The combination of symptoms and imaging findings indicates **advanced pancreatic cancer** where **curative surgery** is not feasible, making **palliative management** the most appropriate approach. *Whipple procedure* - This **pancreaticoduodenectomy** is indicated for **resectable pancreatic head tumors** without **vascular invasion** or **distant metastases**. - The patient's presentation with significant weight loss and chronic pancreatitis suggests **unresectable disease**, making this major surgery inappropriate. *ERCP with stenting* - **Endoscopic stenting** is primarily indicated for **biliary obstruction** with **jaundice** and **elevated bilirubin**. - This patient has **normal liver function tests** and **no jaundice**, indicating no biliary obstruction requiring stenting. *Distal pancreatotomy and splenectomy* - This procedure is appropriate for **resectable tumors** in the **pancreatic body or tail** without **vascular involvement**. - The patient's significant **weight loss** and **chronic pancreatitis** background suggest **advanced unresectable disease**, contraindicting surgical resection.

Q: What is the most common site of ectopic pancreas?

Stomach. **Explanation:** **Ectopic Pancreas** (also known as pancreatic rest or heterotopic pancreas) is defined as pancreatic tissue found outside its normal anatomical location, lacking any vascular or anatomical continuity with the main pancreas. **1. Why Stomach is Correct:** The stomach is the **most common site** for ectopic pancreas, accounting for approximately 25–30% of cases. Within the stomach, it is most frequently found in the **antrum** (along the greater curvature) within the submucosal layer. Histologically, it contains all elements of the normal gland, including acini, ducts, and occasionally Islets of Langerhans. **2. Analysis of Incorrect Options:** * **Meckel’s Diverticulum:** While ectopic pancreas is the **second most common** heterotopic tissue found in Meckel’s diverticulum (after gastric mucosa), it is not the most common site in the body overall. * **Ileum and Appendix:** These are recognized but much rarer sites for pancreatic heterotopia. Other possible sites include the duodenum (second most common overall site after the stomach) and the gallbladder. **3. Clinical Pearls for NEET-PG:** * **Heinrich’s Classification:** Used to categorize ectopic pancreas based on histological components (Type I: all elements; Type II: no islets; Type III: only ducts). * **Clinical Presentation:** Usually asymptomatic and discovered incidentally. However, it can present as a "central umbilication" on endoscopy (Dibiase sign) or cause gastric outlet obstruction or intussusception. * **Differential Diagnosis:** On imaging/endoscopy, it often mimics a Gastrointestinal Stromal Tumor (GIST) or a leiomyoma. * **Hierarchy of Frequency:** Stomach > Duodenum > Jejunum > Meckel’s Diverticulum.

Q: Which of the following laboratory findings or scoring systems indicates severe pancreatitis?

Ranson's score > 3. **Explanation:** Acute pancreatitis severity is determined by the presence of organ failure or local/systemic complications. Scoring systems help predict these outcomes early in the disease course. **Why Ranson’s Score > 3 is Correct:** Ranson’s criteria is a classic prognostic tool specifically designed for acute pancreatitis. It evaluates 11 parameters (5 at admission and 6 within 48 hours). A **Ranson’s score ≥ 3** indicates **severe acute pancreatitis** and correlates with a significant increase in morbidity and mortality. **Analysis of Incorrect Options:** * **APACHE II score > 5:** While APACHE II is an excellent predictor of severity, the threshold for "severe" pancreatitis is a score **≥ 8**. It is more complex but can be calculated daily. * **CRP > 100 mg/dL:** C-reactive protein is a marker of pancreatic necrosis. However, the clinically accepted cut-off for predicting severity is **> 150 mg/L** (measured at 48 hours). * **Hematocrit > 50%:** Hemoconcentration (Hematocrit > 44%) is a risk factor for pancreatic necrosis due to decreased microvascular perfusion, but a specific value of > 50% is not a standardized threshold for defining "severe" pancreatitis in isolation. **High-Yield Clinical Pearls for NEET-PG:** * **Most common cause:** Gallstones (overall), Alcohol (second most common). * **BISAP Score:** (Bedside Index for Severity in Acute Panritis) Uses 5 parameters: **B**UN > 25, **I**mpaired mental status, **S**IRS, **A**ge > 60, **P**leural effusion. A score ≥ 3 indicates high mortality. * **Gold Standard Imaging:** Contrast-Enhanced CT (CECT) is the best investigation to assess necrosis, ideally performed **72–96 hours** after symptom onset. * **Modified Glasgow Score:** Used specifically for gallstone-induced pancreatitis.

Q: What is the primary management of a pancreatic abscess?

Needle aspiration. **Explanation:** The primary management of a pancreatic abscess is **Needle Aspiration** (typically USG or CT-guided). A pancreatic abscess is a late complication of acute pancreatitis, occurring 4+ weeks after the onset, characterized by a circumscribed collection of pus. **Why Needle Aspiration is correct:** In the management of infected pancreatic collections, the initial step is diagnostic and therapeutic aspiration. It allows for Gram staining and culture to guide antibiotic therapy. While many abscesses may eventually require catheter drainage, **percutaneous needle aspiration** remains the standard first-line intervention to confirm the diagnosis and initiate source control in a minimally invasive manner. **Analysis of Incorrect Options:** * **Cystogastrostomy (B) and Cystojejunostomy (D):** These are surgical internal drainage procedures used for **Pancreatic Pseudocysts**, not for acute abscesses. Internal drainage of an infected collection (abscess) is contraindicated as it can lead to worsening sepsis and peritonitis. * **USG guided drainage (C):** While often used, "drainage" usually implies the placement of a large-bore indwelling catheter. In the context of standard surgical teaching (Bailey & Love/Sabiston), the initial step is the aspiration itself. If aspiration fails or the patient remains septic, a formal percutaneous catheter drainage or necrosectomy is considered. **High-Yield Clinical Pearls for NEET-PG:** * **Timeline:** Pancreatic abscess usually develops **>4 weeks** after an attack of acute pancreatitis. * **Diagnosis:** CT scan shows a fluid collection with **internal gas bubbles** (pathognomonic). * **Distinction:** Unlike infected necrosis (which contains solid debris), an abscess is a localized collection of liquid pus. * **Gold Standard for Infected Necrosis:** Step-up approach (starting with percutaneous drainage, followed by minimally invasive necrosectomy if needed).

Q: What is the treatment of choice for cancer of the head of the pancreas?

Whipple's surgery. **Explanation:** The primary goal in managing resectable periampullary and pancreatic head cancers is surgical excision with negative margins (R0 resection). **1. Why Whipple’s Surgery is correct:** **Whipple’s Pancreaticoduodenectomy** is the gold-standard treatment for resectable cancer of the head of the pancreas. The procedure involves the removal of the pancreatic head, duodenum, gallbladder, common bile duct, and sometimes the distal stomach (classic Whipple). This is necessary because the pancreatic head shares a common blood supply (gastroduodenal artery) and anatomical intimacy with the duodenum and biliary tree. **2. Why the other options are incorrect:** * **Options A & B:** Radiotherapy and Chemotherapy are generally used as **adjuvant** (post-surgery) or **neoadjuvant** (pre-surgery) treatments, or as palliative care for unresectable/metastatic disease. They are not curative "treatments of choice" on their own. * **Option D:** Total pancreatectomy (resection of the entire pancreas) is rarely indicated. It does not significantly improve survival compared to the Whipple procedure and results in "brittle diabetes" and severe exocrine insufficiency, significantly reducing the patient's quality of life. **Clinical Pearls for NEET-PG:** * **Resectability Criteria:** A tumor is considered resectable if there is no distant metastasis and no involvement of the Superior Mesenteric Artery (SMA) or Celiac axis. * **Pylorus-Preserving Pancreaticoduodenectomy (PPPD):** A common modification of the Whipple procedure that preserves the entire stomach and pylorus to improve post-operative nutritional status. * **Most Common Site:** 75% of pancreatic cancers occur in the **head**. * **Tumor Marker:** **CA 19-9** is the most specific marker for monitoring recurrence and response to treatment.

Question 1

Which of the following is NOT a risk factor for post-ERCP pancreatitis?

Accepted Answer

Age > 60 years

Answer

Minor papilla sphincterotomy

Answer

Sphincter of Oddi dysfunction

Answer

Age < 60 years

Question 2

What is the gold standard investigation for chronic pancreatitis?

Accepted Answer

ERCP

Answer

MRI

Answer

Pancreatic function tests

Answer

Faecal fat estimation

Question 3

All are true about Zollinger-Ellison syndrome except?

Accepted Answer

Decreased basal acid output (BAO)/maximal acid output (MAO)

Answer

Recurrent ulceration after acid reducing surgery

Answer

Raised gastrin levels in all cases

Answer

Diarrhea

Question 4

All of the following can be used to predict severe acute pancreatitis except?

Accepted Answer

C-reactive protein 
<100

Answer

Glasgow score 
>= 3

Answer

APACHE II score 
>= 8

Answer

CT severity score 
>= 6

Question 5

Which of the following is NOT an operation for chronic pancreatitis?

Accepted Answer

None of the above

Answer

Beger's procedure

Answer

Longitudinal pancreaticojejunostomy

Answer

Frey's procedure

Question 6

A 60-year-old woman with a history of chronic pancreatitis presents with worsening epigastric pain radiating to the back, accompanied by nausea and vomiting. She has experienced a 10 kg weight loss over the past 4 months. There is no evidence of jaundice, and liver function tests and serum amylase/lipase levels are within normal limits. A CT scan of the abdomen reveals significant findings. What is the most appropriate next step in managing this patient?

Accepted Answer

Palliative chemotherapy and best supportive care

Answer

Whipple procedure

Answer

ERCP with stenting

Answer

Distal pancreatotomy and splenectomy

Question 7

What is the most common site of ectopic pancreas?

Accepted Answer

Stomach

Answer

Appendix

Answer

Meckel's diverticulum

Answer

Ileum

Question 8

Which of the following laboratory findings or scoring systems indicates severe pancreatitis?

Accepted Answer

Ranson's score > 3

Answer

APACHE II score > 5

Answer

C-reactive protein (CRP) > 100 mg/dL

Answer

Hematocrit > 50%

Question 9

What is the primary management of a pancreatic abscess?

Accepted Answer

Needle aspiration

Answer

Cystogastrostomy

Answer

USG guided drainage

Answer

Cystojejunostomy

Question 10

What is the treatment of choice for cancer of the head of the pancreas?

Accepted Answer

Whipple's surgery

Answer

Radiotherapy

Answer

Chemotherapy plus radiotherapy

Answer

Resection of the entire pancreas with adjuvant chemotherapy

Pancreatic Surgery — MCQs

Pancreatic Surgery — MCQs

On this page

Practice by Chapter

Want unlimited practice?